Available Technologies

Find technologies available for licensing from UCSF.

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Discovery Of Small Molecules Which Drive Mhc Presentation Of Oncogene Derived Neoantigens

The invention describes a platform technology that increases MHC presentation of oncogene derived peptide neoantigens that do not normally occur in the cell.  The platform has already been used to identify a method of increasing KRAS G12 D/V derived peptide presentation on MHC- I.

Biliary Gene Therapy

Brief description not available